Home » Spinal Restoration Reaches Agreement on Special Protocol for Phase III Trial
Spinal Restoration Reaches Agreement on Special Protocol for Phase III Trial
Spinal Restoration, Inc. announced Tuesday it has received
a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System
for the treatment of chronic discogenic low back pain.
Earth Times
Earth Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May